Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Medical Food (Enterade) for the Reduction of Bowel Movement Frequency in Patients with Neuroendocrine Tumor
This phase II trial studies how well a medical food called enterade works in reducing bowel movement frequency in patients with neuroendocrine tumor. is a commercially available amino acid-based medical food being developed to manage diarrhea due to neuroendocrine tumors either directly (carcinoid syndrome) or indirectly (non-carcinoid syndrome). It may also alleviate abdominal pain or discomfort, bloating, cramping and gas secondary to the disease. Enterade may alleviate neuroendocrine tumor associated diarrhea, provide control of bowel-related symptoms, and improve quality of life in neuroendocrine tumor patients with diarrhea.